Medical Devices North America

North America Insulin Patch Pumps Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

North America Insulin Patch Pumps Market Analysis Industry Trends and Forecast to 2034: Segmented by (By Product Type, By Delivery Mode, By Distribution Channel, By Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

North America · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $494.0 Mn Placeholder estimate
Estimate 2025 $548.3 Mn 49.1% of the global market
Projected 2034 $1.40 Bn 155.8% Adds $854.2 Mn over 9 forecast years
CAGR 2025–2034 11.0% Faster than 72% of 173 Medical Devices markets here
Key players 9 +4
  • North America is 49.11% of the global market.
  • Among regions, the largest is North America (this report) at $548.3 Mn.
  • Fastest growing: Africa at 13.5% a year.
  • North America ranks 1st of 6 by size among regions.

Market size projection

North America

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$854.2 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Insulin Patch Pumps Market market size by year, North America
YearMarket sizeChange that yearSince 2025
2024 (estimate) $494.0 Mn — —
2025 (base) $548.3 Mn +$54.3 Mn —
2026 (forecast) $608.6 Mn +$60.3 Mn +11%
2027 (forecast) $675.5 Mn +$66.9 Mn +23.2%
2028 (forecast) $749.9 Mn +$74.3 Mn +36.8%
2029 (forecast) $832.3 Mn +$82.5 Mn +51.8%
2030 (forecast) $923.9 Mn +$91.6 Mn +68.5%
2031 (forecast) $1.03 Bn +$101.6 Mn +87%
2032 (forecast) $1.14 Bn +$112.8 Mn +107.6%
2033 (forecast) $1.26 Bn +$125.2 Mn +130.5%
2034 (forecast) $1.40 Bn +$139.0 Mn +155.8%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

North America Insulin Patch Pumps Market Analysis at a glance
Market size, 2025$548.3 Mn placeholder estimate
Forecast, 2034$1.40 Bn placeholder estimate
Growth (CAGR), 2025–203411.0% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct type, delivery mode and distribution channel (see all)
Key playersInsulet Corporation, Medtronic, BD (Becton, Dickinson), Tandem Diabetes Care, Valeritas and 4 more (see all)
Active clinical trials8 in North AmericaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in North America. Retrieved 9 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The North America Insulin Patch Pumps Market Executive Summary

An insulin patch pump is a small device that is tubeless which injects fast acting insulin using a needle connected to a patch to be worn on the skin like how a normal pancreas would. Wirelessly controlled, the patch pump is worn on the arms, legs or abdomen. Some features and benefits that set it apart from traditional insulin pumps include tubing complications, compatibility with other devices, user-friendly interface that can be operated by even those with little knowledge of the device, fairly smaller and lightweight than the traditional pump, and fully disposable, which makes it friendly when it comes to the use of the product for diabetes management.

The insulin patch pump market is characterized by stable growth based on the increasing number of diabetics, the development of new technologies and the high demand for an insulin patch pump as an invasive method of injecting insulin. They enhance patient convenience and user simplicity with more features such as compatibility with glucose monitoring and AI for self-regulation. However, high costs and problems with reimbursement present issues, especially in LMICs. Major players holding the market include Insulet Corporation and Medtronic, primarily from the North American region because of the well-established healthcare system. The market is presumed to rise further because wearable technologies and hybrid closed-loop systems are also utilized for managing diabetes.

Bar chart: North America Insulin Patch Pumps market size, 2024–2034, placeholder estimates. $494.0 Mn in 2024, $548.3 Mn in 2025 and $1.40 Bn in 2034, 11.0% CAGR.
North America Insulin Patch Pumps market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

North America Insulin Patch Pumps Market Dynamics

Market Growth Drivers

The growth of the insulin patch pumps market is primarily attributed to the increasing cases of diabetes, Be it type 1 or type 2, which requires an effective approach to insulin delivery. Features like compatibility with continuous glucose monitoring systems and smart insulin delivery further improve the functionality of these devices, making it popular among users. The new pump technologies, understanding, acceptance from the healthcare providers and patients, the ease and comfort associated with patch pumps have led to their growing use. These devices are also cheaper than conventional pumps hence the demand is likely to increase.

Opportunity

Innovations being considered as opportunities for future development of insulin patch pump include utilizing enhanced technologies such as artificial intelligence and machine learning to improve on the functions of insulin patch pump as well as develop mechanisms for automating insulin delivery based on new data. The societal need for less intrusive and convenient products is also increasing, especially among the youth. New opportunities can be found in Asia-Pacific and Latin America as much demand for modern healthcare services arises as infrastructure for it develops. product customization and innovation will improve customer satisfaction.

Market Restraints

There is significant barrier to entry due to cost, even though these devices are cheaper than conventional pumps. Another limitation is the low levels of awareness among patients and healthcare professionals regarding the benefits of using patch pumps. Further, possible adverse effects such as skin irritation and complications in product delivery further indicate the potential threats that manufacturers are likely to face hence struggling to achieve profitability and market dominance.

Competitive Landscape for Insulin Patch Pumps Market in North America

Key Players

Recent Developments

September 2024, embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes.

October 2025, FDA Clears New Insulin Pump and Algorithm-Based Software to Support Enhanced Automatic Insulin Delivery. Agency Continues to Support Innovation of Next-Generation Technology in Diabetes Management.

August 2025, The Accu-Chek Solo micropump system has been cleared by the FDA. The system includes a tubeless insulin pump and a wireless handheld controller with Bluetooth, which integrates with blood glucose monitoring and provides bolus advice.

April 2025, Insulet Announces FDA Clearance of Omnipod GO™, a First-of-its-Kind Basal-Only Insulin Pod, Further Simplifying Life for People with Type 2 Diabetes.

November 2022, Medtronic Launches World's First and Only Infusion Set for Insulin Pumps that Doubles Wear Time up to 7 days in U.S.

Mergers and Acquisitions

May 2025, Medtronic plc announced its acquisition of EOFlow Co. Ltd., the maker of the EOPatch®, a tubeless, wearable insulin delivery device. This acquisition, combined with Medtronic's Meal Detection Technology™ and next-generation continuous glucose monitor (CGM), aims to enhance its diabetes care offerings, providing more flexible insulin delivery options for patients.

December 2022, Tandem Diabetes Care to Acquire Insulin Patch Pump Developer, AMF Medical. Acquisition Expands Addressable Market Opportunity and Complements Family of Insulin Delivery Offerings.

Healthcare Policies and Regulatory Landscape for Insulin Patch Pumps Market in North America

Insulin Patch Pumps in North America: rules, payment and research

In the countries we cover here, medical devices are regulated by Health Canada (Canada)⁠[1] and FDA (US)⁠[2]. How care is paid for in these countries: provincial health insurance (Canada)⁠[3] and Medicare and Medicaid (US)⁠[4]. ClinicalTrials.gov lists 8 studies on Insulin Patch Pumps that are recruiting, active or about to start in North America.⁠[5]

[1] Health Canada. Checked 14 Nov 2026.

[2] US Food and Drug Administration. Checked 14 Nov 2026.

[3] Health Canada. Checked 14 Nov 2026.

[4] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.

[5] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in North America. Retrieved 9 Nov 2026.

Policy changes and Reimbursement scenario

Currently, there is a shift with more insurance companies opening up on the coverage of insulin patch pumps for diabetes management because of focus on early gadget control leading to reduced complications and hence cutting healthcare costs. But concerning reimbursement, it differs from region to region, and the developed market offers better reimbursement than the emerging market. The increased availability of telehealth services due to COVID-19 has also led to insurance programs paying for remote monitoring and consultation in support of home-based diabetes care. There is continued improvement of regulatory policies which enables faster approvals for new products. Also, increasing importance of prevention, and new rules regarding the protection of sensitive patient information influence the reimbursement models and products’ features.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Insulin Patch Pumps right now, from free public sources.

Clinical trials

8 active trials in US and Canada

Recruiting, about to start, or running now. Counted across the 2 countries we report on in North America.

Top trial sponsors (worldwide)

  1. Insulet Corporation 6 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Insulin Patch Pumps in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Insulin Patch Pumps market in North America?
Placeholder estimate: about $548.3 Mn in 2025, rising to about $1.40 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Insulin Patch Pumps market in North America growing?
Placeholder estimate: about 11.0% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Insulin Patch Pumps market report cover?
The report splits the market by product type (Disposable Insulin Patch Pumps, Reusable Insulin Patch Pumps), delivery mode (Basal Delivery, Bolus Delivery, Basal & Bolus Delivery) and distribution channel (Hospitals, Retail Pharmacies, Private Clinics, Online Pharmacies and more).
Who are the key players in the Insulin Patch Pumps market?
Key players include Insulet Corporation, Medtronic, BD (Becton, Dickinson), Tandem Diabetes Care, Valeritas and CeQur, among 9 companies the report profiles.
What is driving the Insulin Patch Pumps market?
The growth of the insulin patch pumps market is primarily attributed to the increasing cases of diabetes, Be it type 1 or type 2, which requires an effective approach to insulin delivery.
How many clinical trials on Insulin Patch Pumps are running in North America?
8 studies are recruiting, active or about to start in North America, counted across the 2 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in North America. Retrieved 9 Nov 2026.
How much research is published on Insulin Patch Pumps?
PubMed lists 137 papers on Insulin Patch Pumps added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 9 Nov 2026.
Back to Catalogue

Related Medical Devices reports in North America

See all

Related on diabetes

See the topic